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Abstract Amylin and epinephrine did not significantly affect 
insulin stimulated, or basal, 3-O-methyiglucose transport in iso- 
lated rat soleus muscle, as measured by the release of 3-O-meth- 
ylglucose from pre-loaded tissue. Both amylin and epinephrine 
inhibited insulin-stimulated 2-deoxyglucose uptake (by 25% and 
38%, respectively) in soleus muscle from fed rats but not from 
fasted rats. The latter results are consistent with amylin and 
epinephrine stimulating glycogenolysis and inhibiting hexokinase 
activity by intracellular accumulation of glucose 6-phosphate. We 
conclude that amylin, like epinephrine, does not specifically in- 
hibit glucose transporters in skeletal muscle. 
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1. Introduction 
Amylin, a 37 amino acid hormone, is synthesized in the 
pancreatic fl cells and co-secreted with insulin [1,2]. The first 
reported biological activity of amylin was the inhibition of 
insulin stimulated incorporation of labeled glucose into glyco- 
gen in soleus muscle preparations, an effect which is now well 
documented [1,3-5]. However, the literature of amylin's effects 
on glucose transport in muscle is confusing and contradictory. 
Some authors report an inhibition of glucose transport [4,6,7], 
whilst others report no effect [7,8]. Part of the confusion ap- 
pears to originate from the interpretation of results showing 
reduced uptake of 2-deoxyglucose, since its uptake does not 
distinguish transport and phosphorylation. In other reports 
using 3-O-methylglucose, a glucose analog that is transported 
but not metabolized, either no effect [4] or an inhibitory effect 
of amylin [7] was demonstrated. These experiments are more 
difficult to perform in isolated tissues such as skeletal muscle 
than they are in isolated cellular preparations, in part because 
the contribution made by the interstitial extracellular space to 
tissue 3-O-methylglucose accumulation is large and unknown, 
and diffusional barriers to 3-O-methylglucose flux prevent us 
from knowing concentrations in the extracellular space that are 
needed for initial influx rate calculations [9]. A technique re- 
ported by Clausen [I0] utilizing the ability of glucose trans- 
porters to transport 3-O-methylglucose out of preloaded cells, 
overcomes most of these issues. We used Clausen's method to 
reexamine the effects of amylin on basal and insulin-stimulated 
glucose transport in skeletal muscle, comparing these effects 
with effects of epinephrine, which acts via receptor-activated 
stimulation of cAMP production, as amylin is believed to do 
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[11 13] We also investigated the effects of amylin on 2-deox- 
yglucose accumulation so they could be compared with effects 
on 3-O-methyl glucose flux. 
2. Materials and methods 
2.1. Animals' and soleus assay 
Soleus muscle strips were obtained from male Sprague-Dawley Rats 
(approximately 170 g), as described [5]. The muscle strips were incu- 
bated in the relaxed state. Most of the experiments used fed animals 
which were allowed food and water ad libitum up to the time of sacri- 
fice, which was within four hours after the beginning of the light cycle. 
In some experiments animals were fasted for approx. 18 h by the 
removal of food and a change of bedding the evening before use. All 
incubations of soleus muscles were performed in 6 well culture plates 
in 2 ml of buffer/well. Culture plates were placed in a Modular Incuba- 
tion Chamber (Billups-Rothenberg, Del Mar, CA) which was flushed 
with 95% 02-5% CO2 for 30 s before placing on an orbital rotator inside 
a 37°C incubator. The incubation chamber was re-flushed each time the 
chamber was opened. 
2.2. Incubations 
2.2.1. 2-Deoxyglucose uptake. 2-Deoxyglucose is transported into 
muscle cells and is phosphorylated byhexokinase into 2-deoxyglucose 
6-phosphate, but is not metabolized further and so can accumulate o 
measurable vels. 2-deoxyglucose uptake experiments were based on 
the method escribed by Kreutter [8]. Briefly, muscles were incubated 
for 15 min in a modified Krebs-Ringer bicarbonate (KRB) buffer 
(118.5 mM NaCI, 5.94 mM KC1, 2.54 mM CaCI2, 1.19 mM MgSO4, 
1.19 mM KH2PO 4 and 25 mM NaHCO3), containing 1 mM [14C]L- 
glucose (0.1 pCi/ml), 2 mM pyruvate and 0.2% BSA. Insulin 7.1 nM 
(Humulin R, Lilly, Indianapolis In), amylin 100 nM (BaChem, Tor- 
rence Ca), or epinephrine 1 pM (Sigma, St Louis Mo), was then added 
and the muscles incubated for another 15 min after which 1 mM [3H]2- 
deoxyglucose (0.2 pCi/ml) was added and the muscles incubated for an 
additional 30 min. At the end of the incubation period, muscles were 
removed from the incubation buffer, rinsed with saline, tendons were 
then removed, the remaining tissue blotted in tissue paper and the 
samples immediately frozen in liquid N2. Soleus muscle samples were 
digested in NaOH and then added to 4 ml of Scintillation fluid (Ecolite, 
ICN) for radioactivity determination by scintillation spectroscopy. 
2.2.2. 3-O-Methylglucose efflux. 3-O-Methylglucose i  transported 
into muscle cells but is not phosphorylated byhexokinase. However, 
because glucose can be transported in either direction (into or from 
cells), inward and outward 3-O-methylglucose fluxes equalize and intra- 
cellular concentration approaches that in the incubation medium so 
that changes in content can no longer measure flux into muscle. How- 
ever efflux of label from loaded cells into a label-free medium can be 
used to measure transport with good sensitivity, and effects due to 
exchange with the interstitial extracellular space can be taken into 
account. 
Methods employed were based on those described by Clausen [10]. 
In the first series of experiments, results shown in Fig. 1, muscles were 
preincubated for 60 min in a modified Krebs-Ringer bicarbonate buffer 
(loading buffer) containing 1.68 mM CaCI2, 0.2% BSA, 1 mM pyruvate, 
1 mM [3H]3-O-methylglucose (l/./Ci/ml) and 1 mM [~4C]L-glucose (1 
,uCi/ml). Muscles were then transferred to 5 ml of the same buffer 
without glucose or label (wash buffer) and rinsed for 2 min by orbital 
rotation at room temperature b fore being transferred to 2 ml of fresh 
wash buffer, with or without insulin, to measure fflux of label. At the 
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end of the efflux incubation, muscle samples were removed, rinsed, 
trimmed, and frozen as described above. The muscle content of [J4C]L- 
glucose and [3H]3-O-methylglucose was determined as described 
above. 
In a second series of experiments muscles were first incubated for 60 
min in loading buffer containing 4.5 #Ci/ml of [3H]3-O-methylglucose 
and were then briefly washed as described above. Muscle pieces were 
then transferred to fresh wash buffer (1 soleus muscle strip/well in 2 ml 
of buffer). Hormones were added after 40 min of efflux incubation. 
Efflux of label from the muscle into the incubation buffer was followed 
by taking duplicate 50 #1 samples of the efflux buffer every 10 min for 
30 min. At the end of the incubation period muscle pieces were rinsed, 
blotted and frozen as described above to determine 3H content. 
2.3. Numerical methods' 
Specific uptake of 2-deoxyglucose was calculated by subtracting the 
extracellular t apping of L-glucose. The rate of 2-deoxyglucose uptake 
is expressed as nmol 2-deoxyglucose/g wet weight/rain. Statistical signif- 
icance was determined by use of the Student's t-test (Instat). 
In Fig. l, the glucose content of the muscle is expressed as nmol/g 
wet wt. The rate of 3-O-methylglucose appearance in the efflux buffer 
appeared to be constant between 40 and 70 rain (results not shown). 
Scintigraphy of bathing media and digested muscles at the end of 
experiments enabled calculation of the total radiography that had been 
loaded into muscle before fflux was observed. The rate of efflux in Fig. 
2 was expressed as the percent of this initial content hat was released 
into the efflux buffer per min [10] between 40 and 70 min of the 
incubation. 
3. Results and discussion 
Fig. 1 shows a rapid efflux of both 3-O-methyl glucose and 
L-glucose from pre-loaded tissue. It can be seen that after 40 
min of incubation, the rate of L-glucose efflux from muscle 
approaches zero whilst 3-O-methylglucose in muscle continues 
to decline at an essentially linear rate. The results suggest hat 
efflux during the initial 40 min of incubation represents diffu- 
sion of label from the interstitial space and that after 40 min 
efflux mostly represents transport from intracellular compart- 
ments. The results also repeat a previous observation [10] that 
insulin rapidly stimulates the efflux of 3-O-methylglucose glu- 
cose transport (which is transported by specific carriers) but 
has no effect on the efflux of L-glucose (which diffuses like 
D-glucose, but is not transported). 
In the following series of experiments hormone additions 
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Fig. 1. Release of preloaded glucose from isolated rat soleus muscle. 
Isolated soleus muscle strips were incubated with [3H]3-O-methylglu- 
cose (t  ©) and [~4C]L-glucose (I, []) for 60 min prior to being incubated 
in label-free buffer in the presence (t, i )  or absence (©, E3) of insulin. 
The glucose content of the muscles at the times indicated was calculated 
as described in the methods. Results are means + S.E. of quadruplicate 
muscle strips from a representative experiment. 
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Fig, 2. Rate of 3-O-methylglucose efflux from preloaded isolated rat 
soleus muscle. Muscles were incubated with [3H]3-O-methylglucose as 
described above and then further incubated with label-free buffer for 
40 rain after which hormones were added as indicated and incubations 
continued for an additional 30 min. The rate of efflux of label during 
this 30 min period was followed by taking samples of the incubation 
buffer and determining the label-content ofthe muscle at the end of the 
incubation, and is expressed as the percent of this initial content of label 
that was released into the efflux buffer per min. Results are 
means + S.E. of 9-15 muscle strips from 3-4 independent experiments. 
were made at the 40 min time point and incubations were 
continued for an additional 30 min. Fig. 2 shows the average 
rate of 3-O-methylglucose efflux from the tissue into the sur- 
rounding media during the 30 min. hormones were present. 
Insulin stimulated basal 3-O-methylglucose efflux by approxi- 
mately 80%. Neither amylin nor epinephrine significantly af- 
fected either basal or insulin-stimulated glucose transport. Sim- 
ilar results were obtained using muscles from fed or fasted rats 
(results not shown). A tendency for amylin and epinephrine to 
stimulate the basal rate of 3-O-methylglucose efflux, as has 
been reported previously for epinephrine in rat skeletal muscle 
and [14] and human adipocytes [15], failed to reach significance 
in these experiments. 
Fig. 3 shows 2-deoxyglucose uptake by isolated soleus mus- 
cles from both fed and lasted rats. Insulin stimulated 2-deox- 
yglucose accumulation by 244% and 141% in muscles from fed 
and fasted rats respectively, consistent with previously reported 
values [16,17]. Amylin or epinephrine did not affect basal 2- 
deoxyglucose uptake in muscles from fed or fasted rats and 
neither agent affected insulin stimulated 2-deoxyglucose accu- 
mulation in muscles from fasted rats. In muscles from fed rats, 
both amylin and epinephrine tended to decrease insulin stimu- 
lated 2-deoxyglucose accumulation (25% decrease, P = 0.19 
and 38% decrease, P -- 0.09, respectively). Leighton and Coo- 
per [6] failed to show an effect of amylin on insulin stimulated 
2-deoxyglucose accumulation, whereas Kreutter et al. [8] and 
Young et al. [7] reported that amylin inhibited insulin-stimu- 
lated 2-deoxyglucose accumulation by 65 and 45%, respec- 
tively. 
The lack of effect of amylin and epinephrine on 3-O-meth- 
ylglucose effiux indicates these agents did not directly affect 
glucose transport o any physiologically significant extent. Inhi- 
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Fig. 3. Rate of 2-deoxyglucose uptake in isolated rat soleus muscle. 
Muscle strips were incubated with hormones as indicated for 15 min 
prior to the addition of [3H]2-deoxyglucose for 30 min. Results are 
expressed as nmol 2-deoxyglucose uptake/min/mg wet wt. and are 
means + S.E. of 8 12 muscle strips from 2-3 independent experiments. 
bition of 2-deoxyglucose accumulation may result from the 
indirect inhibition of hexokinase activity [18] likely to follow 
elevated glucose 6-phosphate [7] concentrations observed after 
amylin (or epinephrine) stimulation of glycogenolysis. Com- 
pared to those in fed rats, muscles from fasted rats have less 
glycogen [19] which could be expected to produce a smaller 
G-6-P pool under glycogenolytic conditions and hence not in- 
hibit hexokinase activity as much. 
We conclude that amylin, like epinephrine, is unlikely to 
directly affect glucose transport in skeletal muscle. Our results 
are consistent with amylin (and epinephrine) decreasing glucose 
uptake indirectly by inhibiting hexokinase through activation 
of glycogenolysis and thus elevation glucose 6-phosphate l vels. 
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